XORTX Therapeutics Inc. - XRTX

About Gravity Analytica
Recent News
- 10.29.2025 - XORTX Announces Closing of US$1.1 Million Registered Direct Offering
- 10.29.2025 - XORTX Announces Closing of US$1.1 Million Registered Direct Offering
- 10.21.2025 - XORTX Announces Pricing of US$1.1 Million Registered Direct Offering
- 10.21.2025 - XORTX Announces Pricing of US$1.1 Million Registered Direct Offering
- 10.21.2025 - XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
- 10.21.2025 - XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
- 10.20.2025 - XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- 10.20.2025 - XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Recent Filings
- 10.29.2025 - EX-99.1 EX-99.1
- 10.29.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 10.27.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
- 10.23.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 10.23.2025 - 424B5 Prospectus [Rule 424(b)(5)]
- 10.23.2025 - EX-99.1 EX-99.1
- 10.21.2025 - EX-99.1 EX-99.1
- 10.21.2025 - EX-99.1 EX-99.1
- 10.21.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 10.21.2025 - EX-99.1 EX-99.1